IP Library › Assignment 061299/0927
Patent Assignment
Reel/Frame 061299/0927

Release of Security Interest

Recorded: 2022-10-04 Pages: 4
Assignor
Assignee
ESPERO BIOPHARMA, INC.
14286-19 BEACH BLVD., #270, JACKSONVILLE, FLORIDA, 32250
Covered Properties (5)
Materials and Methods for Treating Coagulation Disorders
Patent: 7,145,020 →
Application: 10/822,129 →
Publication: US 2004/0220258
Materials and Methods for Treating Coagulation Disorders
Patent: 7,253,208 →
Application: 11/101,714 →
Publication: US 2005/0245603
Materials and Methods for Treating Coagulation Disorders
Patent: 7,285,671 →
Application: 11/467,813 →
Publication: US 2006/0287388
Haloalkyl Ester Derivatives of Coumarin for the Treatment of Coagulation Disorders
Patent: 7,666,902 →
Application: 11/778,482 →
Publication: US 2008/0027132
Halogenated Ester Derivatives of Coumarins for the Treatment of Coagulation Disorders
Patent: 7,932,405 →
Application: 12/268,109 →
Publication: US 2009/0082430
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 025006 Frame 0740. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics. the Assignee Name Should Not Have Had Inc. May 31, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028307/0394 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0155. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics, Inc.. Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0203 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 022529 Frame 0584. Assignor(S) Hereby Confirms the Name of the Assignee to Be Aryx Therapeutics and Not Aryx Therapeutics, Inc.. Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0196 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0203. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics Inc. Jun 8, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028349/0801 →
Assignment of Assignor's Interest Jun 8, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 028347/0389 →
Assignment of Assignor's Interest Jun 20, 2012
From: DRUZGALA, PASCAL; ZHANG, XIAOMING; PFISTER, JURG
To: ARYX THERAPEUTICS
Reel/Frame 028411/0068 →
Release of Security Interest Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Security Interest Apr 16, 2019
From: ESPERO BIOPHARMA, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048918/0544 →
Change of Name Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest Oct 23, 2020
From: ESPERO BIOPHARMA, INC.
To: HESP LLC
Reel/Frame 054150/0011 →
Assignment of Assignor's Interest May 4, 2022
From: HESP LLC
To: CADRENAL THERAPEUTICS
Reel/Frame 059811/0221 →